Some of these RA risk SNPs, such as IRF5 polymorphisms, associate with more severe or erosive disease [93, 94], which may corroborate the clinical refractory disease phenotype observed in IGS high early RA patients [12••]. This evidence concerns the gene IRF5 and rheumatoid arthritis.